Vik Chopra
Stock Analyst at Wells Fargo
(2.24)
# 1,486
Out of 4,667 analysts
25
Total ratings
50%
Success rate
-0.93%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $9.19 | +41.46% | 2 | Nov 13, 2024 | |
GMED Globus Medical | Maintains: Overweight | $78 → $88 | $83.59 | +5.28% | 7 | Nov 6, 2024 | |
MASI Masimo | Maintains: Overweight | $160 → $171 | $164.95 | +3.67% | 6 | Nov 6, 2024 | |
NVST Envista Holdings | Initiates: Equal-Weight | $20 | $20.37 | -1.82% | 1 | Oct 8, 2024 | |
SOLV Solventum | Maintains: Equal-Weight | $69 → $64 | $68.39 | -6.42% | 2 | Aug 9, 2024 | |
CNMD CONMED | Maintains: Equal-Weight | $77 → $71 | $70.69 | +0.44% | 2 | Aug 1, 2024 | |
ATEC Alphatec Holdings | Maintains: Overweight | $26 → $19 | $9.93 | +91.34% | 1 | Aug 1, 2024 | |
IART Integra LifeSciences Holdings | Downgrades: Equal-Weight | $45 → $25 | $22.93 | +9.03% | 1 | May 7, 2024 | |
ENOV Enovis | Maintains: Overweight | $73 → $79 | $44.78 | +76.42% | 3 | Feb 23, 2024 |
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $9.19
Upside: +41.46%
Globus Medical
Nov 6, 2024
Maintains: Overweight
Price Target: $78 → $88
Current: $83.59
Upside: +5.28%
Masimo
Nov 6, 2024
Maintains: Overweight
Price Target: $160 → $171
Current: $164.95
Upside: +3.67%
Envista Holdings
Oct 8, 2024
Initiates: Equal-Weight
Price Target: $20
Current: $20.37
Upside: -1.82%
Solventum
Aug 9, 2024
Maintains: Equal-Weight
Price Target: $69 → $64
Current: $68.39
Upside: -6.42%
CONMED
Aug 1, 2024
Maintains: Equal-Weight
Price Target: $77 → $71
Current: $70.69
Upside: +0.44%
Alphatec Holdings
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $9.93
Upside: +91.34%
Integra LifeSciences Holdings
May 7, 2024
Downgrades: Equal-Weight
Price Target: $45 → $25
Current: $22.93
Upside: +9.03%
Enovis
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $44.78
Upside: +76.42%